×
For best experience we recommend to activate Javascript in your browser.
PLA2R1 antibody (AA 242-507)
This Rabbit Polyclonal antibody specifically detects PLA2R1 in WB, ELISA and IHC. It exhibits reactivity toward Mouse.
Quick Overview for PLA2R1 antibody (AA 242-507) (ABIN7570745)
Target
See all PLA2R1 Antibodies
PLA2R1
(phospholipase A2 Receptor 1, 180kDa (PLA2R1))
Reactivity
All reactivities for PLA2R1 antibodies
Mouse
Host
All hosts for PLA2R1 antibodies
Rabbit
Clonality
All clonalities for PLA2R1 antibodies
Polyclonal
Conjugate
All conjugates for PLA2R1 antibodies
This PLA2R1 antibody is un-conjugated
Application
All applications for PLA2R1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-PLA2R1 Antibody
(hide)
Binding Specificity
All epitopes for PLA2R1 antibodies
AA 242-507
Purpose
Anti-Mouse PLA2R1/PLA2R Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Mouse PLA2R1/PLA2R (Ser242-Gly507).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for PLA2R1
(hide)
Target
PLA2R1
(phospholipase A2 Receptor 1, 180kDa (PLA2R1))
Alternative Name
PLA2R1
Background
PLA2R, 180 kDa secretory phospholipase A2 receptor, Secretory phospholipase A2 receptor, PLA2-R, M-type receptor, C-type lectin domain family 13 member C, Soluble PLA2-R, PLA2R1, Soluble PLA2R, CLEC13C,
UniProt
Q62028
Pathways
Positive Regulation of Response to DNA Damage Stimulus
Recently viewed
(hide)
Chat with us , powered by LiveChat